1,825
Views
117
CrossRef citations to date
0
Altmetric
Review

Next-generation sequencing: advances and applications in cancer diagnosis

, , , , , & show all
Pages 7355-7365 | Published online: 02 Dec 2016

References

  • LiWZhaoKKirbergerMLiaoWYanYNext generation sequencing technologies in cancer diagnostics and therapeutics: a mini reviewCell Mol Biol (Noisy-le-grand)20156159110226522064
  • QuailMASmithMCouplandPA tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencersBMC Genomics20121334122827831
  • RossMGRussCCostelloMCharacterizing and measuring bias in sequence dataGenome Biol2013145R5123718773
  • D’ArgenioVEspositoMVTeleseAThe molecular analysis of BRCA1 and BRCA2: next-generation sequencing supersedes conventional approachesClin Chim Acta201544622122525896959
  • TarabeuxJZeitouniBMoncoutierVStreamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a modelEur J Hum Genet201422453554123942203
  • PilatoBPintoRDe SummaSBRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final reportGenes Chromosomes Cancer2016551080381327225819
  • TungNBattelliCAllenBFrequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panelCancer20151211253325186627
  • LinPHKuoWHHuangACMultiple gene sequencing for risk assessment in patients with early-onset or familial breast cancerOncotarget2016778310832026824983
  • LhotaFZemankovaPKleiblovaPHereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patientsClin Genet201690432433326822949
  • StromCMRiveraSElzingaCDevelopment and validation of a next-generation sequencing assay for BRCA1 and BRCA2 variants for the clinical laboratoryPLoS One2015108e013641926295337
  • IhleMAFassunkeJKönigKComparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutationsBMC Cancer2014141324410877
  • van Engen-van GrunsvenACKusters-VandeveldeHGroenenPJBlokxWAUpdate on molecular pathology of cutaneous melanocytic lesions: what is new in diagnosis and molecular testing for treatment?Front Med (Lausanne)201413925593912
  • PintoRDe SummaSStrippoliSThe next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy responseOncotarget2016718251352514926863566
  • ChenJZhangDYanWYangDShenBTranslational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing eraBiomed Res Int2013201390157823957008
  • Manson-BahrDBallRGundemGMutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencingJ Clin Pathol201568321221725586381
  • IaconoMLButtiglieroCMonicaVRetrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancerOncotarget2016712143941440426887047
  • NikiforovaMNWaldAIRoySDursoMBNikiforovYETargeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancerJ Clin Endocrinol Metab20139811E1852E186023979959
  • NikiforovYECartySEChioseaSIHighly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assayCancer2014120233627363425209362
  • NikiforovYECartySEChioseaSIImpact of the multi-gene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytologyThyroid201525111217122326356635
  • SimboloMMianCBarolloSHigh-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomasVirchows Arch20144651737824828033
  • SequistLVWaltmanBADias-SantagataDGenotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitorsSci Transl Med201137575ra26
  • YuHAArcilaMERekhtmanNAnalysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancersClin Cancer Res20131982240224723470965
  • WalterAOSjinRTHaringsmaHJDiscovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLCCancer Discov20133121404141524065731
  • CrossDAAshtonSEGhiorghiuSAZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancerCancer Discov2014491046106124893891
  • MasagoKFujitaSMurakiMNext-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutationsBMC Cancer20151590826572169
  • RangachariDVanderLaanPALeXExperience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practiceCancer Treat Commun2015417418126601054
  • ShaoDLinYLiuJA targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinomaSci Rep201662233826936516
  • LimSMKimEYKimHRGenomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negativeOncotarget2016717241722417826992220
  • ScarpaASikoraKFassanMMolecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panelPLoS One2013811e8047824236184
  • TopsBBNormannoNKurthHDevelopment of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortiumBMC Cancer2015152625637035
  • QiuTGuoHZhaoHWangLZhangZNext-generation sequencing for molecular diagnosis of lung adenocarcinoma specimens obtained by fine needle aspiration cytologySci Rep201551131726066407
  • TreeceALMontgomeryNDPatelNMFNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomasCancer Cytopathol2016124640641426882436
  • UchidaJKatoKKukitaYDiagnostic accuracy of noninvasive genotyping of EGFR in lung cancer patients by deep sequencing of plasma cell-free DNAClin Chem20156191191119626206882
  • SchwaederleMHusainHFantaPTDetection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assayOncotarget2016799707971726848768
  • QueDXiaoHZhaoBZhangXWangQWangGEGFR mutation status in plasma and tumor tissues in non-small cell lung cancer serves as a predictor of response to EGFR-TKI treatmentCancer Biol Ther201617332032726785777
  • XuSLouFWuYCirculating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patientsCancer Lett2016370232433126582655
  • MarchettiAPalmaJFFelicioniLEarly prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patientsJ Thorac Oncol201510101437144326295376
  • TherkildsenCBergmannTKHenrichsen-SchnackTLadelundSNilbertMThe predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: a systematic review and meta-analysisActa Oncol201453785286424666267
  • GaoJWuHWangLValidation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCRBMJ Open201661e009532
  • BelardinilliFCapalboCBuffoneAValidation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancerClin Biochem20154813–1490891025872148
  • D’HaeneNLe MercierMDe NeveNClinical validation of targeted next generation sequencing for colon and lung cancersPLoS One2015109e013824526366557
  • HaleyLTsengLHZhengGPerformance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancersMod Pathol201528101390139926226847
  • StadlerZKBattaglinFMiddhaSReliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next- generation sequencing panelsJ Clin Oncol201634182141214727022117
  • HsuHCThiamTKLuYJMutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patientsOncotarget2016716222572227026989027
  • MalapelleUPisapiaPSgarigliaRLess frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine casesJ Clin Pathol201669976777126797410
  • JesinghausMPfarrNEndrisVGenotyping of colorectal cancer for cancer precision medicine: results from the IPH Center for Molecular PathologyGenes Chromosomes Cancer201655650552126917275
  • WangSRMalikSTanIBTechnical validation of a next-generation sequencing assay for detecting actionable mutations in patients with gastrointestinal cancerJ Mol Diagn201618341642426970585
  • HussainiMBiomarkers in hematological malignancies: a review of molecular testing in hematopathologyCancer Control201522215816626068760
  • BlackJSSalto-TellezMMillsKICatherwoodMAThe impact of next generation sequencing technologies on haematological research: a reviewPathogenesis201521–2916
  • MorganGJWalkerBADaviesFEThe genetic architecture of multiple myelomaNat Rev Cancer201212533534822495321
  • ChapmanMALawrenceMSKeatsJJInitial genome sequencing and analysis of multiple myelomaNature2011471733946747221430775
  • WalkerBAWardellCPMelchorLIntraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptomsLeukemia201428238439023817176
  • BolliNAvet-LoiseauHWedgeDCHeterogeneity of genomic evolution and mutational profiles in multiple myelomaNat Commun20145299724429703
  • KortümKMLangerCMongeJLongitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P)Ann Hematol20159471205121125743686
  • HallekMChesonBDCatovskyDGuidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute: Working Group 1996 guidelinesBlood2008111125446545618216293
  • QuesadaVCondeLVillamorNExome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemiaNat Genet20124414752
  • FahamMZhengJMoorheadMDeep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemiaBlood2012120265173518023074282
  • LadettoMBruggemannMMonitilloLNext-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersLeukemia20142861299130724342950
  • NielsenRPaulJSAlbrechtsenASongYSGenotype and SNP calling from next-generation sequencing dataNat Rev Genet201112644345121587300
  • CostaJLSousaSJustinoANonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic settingHum Mutat201334462963523315985
  • RothbergJMHinzWRearickTMAn integrated semiconductor device enabling non-optical genome sequencingNature2011475735634835221776081
  • ZookJMChapmanBWangJIntegrating human sequence data sets provides a resource of benchmark SNP and indel genotype callsNat Biotechnol201432324625124531798
  • VanniICocoSTruiniANext-generation sequencing workflow for NSCLC critical samples using a targeted sequencing approach by Ion Torrent PGM platformInt J Mol Sci20151612287652878226633390
  • LiuBMorrisonCDJohnsonCSComputational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challengesOncotarget20134111868188124240121
  • HoogstraatMHinrichsJWBesselinkNJSimultaneous detection of clinically relevant mutations and amplifications for routine cancer pathologyJ Mol Diagn2015171101825445215
  • GrassoCButlerTRhodesKAssessing copy number alterations in targeted, amplicon-based next-generation sequencing dataJ Mol Diagn2015171536325468433
  • BudcziesJPfarrNStenzingerAIoncopy: a novel method for calling copy number alterations in amplicon sequencing data including significance assessmentOncotarget2016711132361324726910888